CARA heading to 12.80 Viés de alta

Cara Therapeutics, Inc.NASDAQ

Descrição

⋅ 9 de Jan de 2017 19:41

As biotech's (IBB, LABU) lose fear of Trump, CARA should to well. Ist tgt. 12.80.